Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Unveiling DENND2D as a Novel Prognostic Biomarker for Prostate Cancer Recurrence: From Gene to Prognosis

26 Dec 2024

Abstract excerpt

Background: Prostate cancer is a major global health burden, with biochemical recurrence (BCR) following radical prostatectomy affecting 20–40% of patients and posing significant challenges to prognosis and treatment. Emerging evidence suggests a critical role for differentially expressed in normal and neoplastic cell (DENN) domain-containing genes in oncogenesis; however, their implications in prostate cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39857609
DOI: 10.3390/biomedicines13010025

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Unveiling DENND2D as a Novel Prognostic Biomarker for Prostate Cancer Recurrence: From Gene to PrognosisPMID 39857609Read ↗

BRD9 Expression, Alteration, Survival And Pathway Analysis In 11 Independent Prostate Cancer CohortsSemantic proximity Read ↗

Susceptibility-Associated Genetic Variation in NEDD9 Contributes to Prostate Cancer Initiation and Progression.Semantic proximity Read ↗

Comprehensive multi-omics analysis reveals the molecular mechanism of prostate cancer recurrenceSemantic proximity Read ↗

NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesisSemantic proximity Read ↗

Comprehensive Analysis of Cell Cycle-Related Genes in Patients With Prostate CancerSemantic proximity Read ↗

A Tumor Suppressor-Regulated Cell Cycle Derived Gene Signature is Prognostic of Recurrence Risk in Prostate CancerSemantic proximity Read ↗

LNCaP Atlas: Gene expression associated with in vivoprogression to castration-recurrent prostate cancerSemantic proximity Read ↗

Prognostic Value of CD1B in Localised Prostate Cancer.Semantic proximity Read ↗

Tumor-antigens and immune landscapes identification for prostate adenocarcinoma mRNA vaccineSemantic proximity Read ↗

Immune checkpoint-related serum proteins and genetic variants predict outcomes of localized prostate cancer, a cohort study.Semantic proximity Read ↗

CDHu40: a novel marker gene set of neuroendocrine prostate cancer (NEPC)Semantic proximity Read ↗

Differentially Expressed Genes Associated With Prognosis in Locally Advanced Lymph Node-Negative Prostate CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.